Loading patent…
AssigneesBaxalta Incorporated, Children's Medical Center Corporation
InventorsDenisa D. Wagner, Anil Kumar CHAUHAN, Friedrich SCHEIFLINGER, Barbara PLAIMAUER
Estimating the term…
This invention relates to a pharmaceutical composition having thrombolytic activity comprising ADAMTS13, and to methods for treating or preventing a disorder associated with the formation and/or the presence of one or more thrombus and to methods of disintegrating one or more thrombus in a patient in need thereof. Furthermore, the invention relates to the use of a pharmaceutically effective amount of ADAMTS13 for the preparation of a pharmaceutical composition for treating or preventing a disorder associated with the formation or the presence of one or more thrombus and for disintegrating one or more thrombus in a patient in need thereof.
1-7. (canceled)
A method of treating deep vein thrombosis in a patient, the method comprising administering ADAMTS13 to the patient.
A method of treating deep vein thrombosis in a patient, the method comprising administering a chimeric molecule comprising ADAMTS13 and Ig.
A method of disintegrating one or more thrombi in a patient, the method comprising administering ADAMTS13 to the patient.
Dependencies are inferred from the claim text.